In the cannabis industry, COVID-19 was a transformative “inflection point” that accelerated the industry’s maturity by at least a decade. It fundamentally shifted how cannabis is viewed by the government, how it is sold by retailers, and how it is consumed by the public. As of February 2026, the “COVID-legacy” defines the current operational standards of the global market.